Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction

In patients with heart failure with reduced ejection fraction (HFrEF), individual responses to beta-blockers vary. Candidate gene pharmacogenetic studies yielded significant but inconsistent results, and they may have missed important associations. Our objective was to use an unbiased genome-wide as...

Descripción completa

Detalles Bibliográficos
Autores principales: Luzum, Jasmine A., Campos-Staffico, Alessandra M., Li, Jia, She, Ruicong, Gui, Hongsheng, Peterson, Edward L., Liu, Bin, Sabbah, Hani N., Donahue, Mark P., Kraus, William E., Williams, L. Keoki, Lanfear, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671316/
https://www.ncbi.nlm.nih.gov/pubmed/38002962
http://dx.doi.org/10.3390/genes14112019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671316/
https://www.ncbi.nlm.nih.gov/pubmed/38002962
http://dx.doi.org/10.3390/genes14112019

Ejemplares similares